Cetera Investment Advisers Hepion Pharmaceuticals, Inc. Transaction History

Cetera Investment Advisers

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.31 - $1.06 $3,095 - $10,585	-9,986 Reduced 33.59%	19,746 $15,000
Q4 2022 Feb 14, 2023	BUY	$0.27 - $11.9 $4,983 - $219,662	18,459 Added 163.75%	29,732 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.51 - $10.4 $5,749 - $117,239	11,273 New	11,273 $6,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

Stay updated on Cetera Investment Advisers with notifications on news.